longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Shanghai Municipal Health Commission: Promote the development of medical artificial intelligence and advance the improvement of the fertility support policy system

Zhitong
Feb 27, 2025 at 02:46 AM

On February 26, the Shanghai Municipal Health Commission issued the "Key Points for Health and Health Work in Shanghai in 2025," covering a total of 37 items in seven areas, including promoting the quality improvement of the health service system, advancing health technology innovation, and digital transformation. This includes promoting the development of medical artificial intelligence and advancing the implementation of a number of new scenarios and models as planned. It also aims to improve the fertility support policy system and work with relevant departments to research, formulate, and implement a fertility subsidy system. In terms of promoting health technology innovation and digital transformation, the "Key Points" focus on original innovation and key core technologies, strengthening major scientific tasks and breakthroughs, and striving to make Shanghai a source of health technology innovation. It promotes digital empowerment for industry development, advances the development of medical artificial intelligence, and implements a number of new scenarios and models as planned. It aims to build a clinical diagnosis and treatment decision support knowledge base and establish a corpus for clinical medicine, public health, traditional Chinese medicine, and health management. It will also formulate standards for data circulation and utilization, and basically complete the foundational framework functions of the municipal health big data platform and the governance of historical data integration

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

GUANGJI PHARMA

GUANGJI PHARMA

SZ000952

-4.01%

Huatai-PB CSI Chinese Medicine ETF

Huatai-PB CSI Chinese Medicine ETF

SH561510

LongbridgeAI